The 12th annual OCT New England event will be turning virtual in September to become OCT USA.
As the industry grapples with unprecedented challenges, join us for the first ever Outsourcing in Clinical Trials USA virtual conference brought to you directly in the comfort of your home! Bringing together experts from across the USA to discuss the latest innovations in outsourcing, technology, regulatory affairs and medical devices, this virtual conference will deliver cutting-edge content on how best to manage outsourcing strategies.
Our 2 day event will be fully online and free to attend, allowing you to connect with others across the industry by:
- Listening to our world class speakers in the auditorium
- Engaging in discussions with your peers in our networking lounge
- Learning about our exhibitors’ solutions to improve your virtual clinical trial in the exhibition hall
SNEAK PEEK
It is becoming clear that the only options are to disrupt or be disrupted: and so this event is focused on examining real world evidence into innovations and industry trends that you cannot afford to miss.
It is becoming clear that the only options are to disrupt or be disrupted: and so this event is focused on examining real world evidence into innovations and industry trends that you cannot afford to miss.
Here’s a preview of some of our sessions…
- Drug Development Trends and their Impact on Clinical Trial Execution, Ken Getz, Deputy Director, Research Professor (PCHM), Centre for the Study of Drug Development, Tufts University
- Shaping the Future of Clinical Trial: What’s Coming Up Next in Digital Medicine and Innovative Technology, Amir Lahav, Executive Director and Head of Digital Medicine, Karyopharm
- Site engagement during the site feasibility process and the impact on study start-Up timelines, Sandeep Menon, Senior Vice President and Head of Early Clinical Development, Pfizer
